Allakos Inc

2
1
NAS:ALLK (USA)  
$ 1.16 -0.08 (-6.45%) 10:08 PM EST
At Loss
P/B:
0.99
Market Cap:
$ 102.71M
Enterprise V:
$ 3.89M
Volume:
338.55K
Avg Vol (2M):
461.10K
Trade In:
Volume:
338.55K
At Loss
Avg Vol (2M):
461.10K

Business Description

Description
Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation.
Name Current Vs Industry Vs History
Cash-To-Debt 3.44
Equity-to-Asset 0.59
Debt-to-Equity 0.39
Debt-to-EBITDA -0.21
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 32.62
9-Day RSI 40.13
14-Day RSI 43.84
6-1 Month Momentum % -62.22
12-1 Month Momentum % -75.71

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.11
Quick Ratio 4.11
Cash Ratio 3.88

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -18.2
Shareholder Yield % 6.82

Financials (Next Earnings Date:2024-08-09 Est.)

ALLK's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ALLK

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Allakos Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -2.46
Beta 0.36
Volatility % 92.11
14-Day RSI 43.84
14-Day ATR ($) 0.103566
20-Day SMA ($) 1.286
12-1 Month Momentum % -75.71
52-Week Range ($) 0.9799 - 5.64
Shares Outstanding (Mil) 88.54

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Allakos Inc Filings

Filing Date Document Date Form
No Filing Data

Allakos Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Allakos Inc Frequently Asked Questions

What is Allakos Inc(ALLK)'s stock price today?
The current price of ALLK is $1.16. The 52 week high of ALLK is $5.64 and 52 week low is $0.98.
When is next earnings date of Allakos Inc(ALLK)?
The next earnings date of Allakos Inc(ALLK) is 2024-08-09 Est..
Does Allakos Inc(ALLK) pay dividends? If so, how much?
Allakos Inc(ALLK) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1